BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 339932)

  • 1. Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
    Perks WH; Chatterjee SS; Croxson RS; Cruickshank JM
    Br J Clin Pharmacol; 1978 Feb; 5(2):101-6. PubMed ID: 339932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselectivity of atenolol in asthmatic patients.
    Ellis ME; Sahay JN; Chatterjee SS; Cruickshank JM; Ellis SH
    Eur J Clin Pharmacol; 1981; 21(3):173-6. PubMed ID: 7032947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction.
    Jaiprakash SS; Sahay JN; Chatterjee SS; MacDonald G
    Postgrad Med J; 1980 Sep; 56(659):624-8. PubMed ID: 7008048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
    Aström H; Vallin H
    Postgrad Med J; 1977; 53 Suppl 3():84. PubMed ID: 928272
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of atenolol on ventilatory and cardiac function in asthma.
    Vilsvik JS; Schaanning J
    Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
    Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
    van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxprenolol on the airways of normal and bronchitic subjects.
    Addis GJ; Thorp JM
    Eur J Clin Pharmacol; 1976 Feb; 9(4):259-63. PubMed ID: 786691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics.
    Majid PA; van der Vijgh WJ; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    Eur J Cardiol; 1979 Jun; 9(6):419-35. PubMed ID: 381009
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.
    Groth S; Tønnesen P; Asted M; Dirksen H; Sørensen PG
    Eur J Clin Pharmacol; 1986; 30(6):653-8. PubMed ID: 3533563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.